Cargando…
Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps
Aim: The efficacy and safety of allergen immunotherapy (AIT) in allergic rhinitis has been classically assessed using randomized controlled trials (RCTs). However, RCTs may have limitations in their external validity, and their evidence may be complemented with that from real-world studies. We aimed...
Autores principales: | Sousa-Pinto, Bernardo, Pfaar, Oliver, Bousquet, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012883/ https://www.ncbi.nlm.nih.gov/pubmed/36925994 http://dx.doi.org/10.5414/ALX02343E |
Ejemplares similares
-
Digital health for allergen immunotherapy
por: Dramburg, Stephanie, et al.
Publicado: (2022) -
Placebo effects in allergen immunotherapy: an experts’ opinion
por: Frew, Anthony J., et al.
Publicado: (2018) -
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities
por: Sousa‐Pinto, Bernardo, et al.
Publicado: (2022) -
Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy
por: Pfaar, O., et al.
Publicado: (2020) -
Usability and Feasibility of PIERS on the Move: An mHealth App for Pre-Eclampsia Triage
por: Lim, Joanne, et al.
Publicado: (2015)